Mark Harvey Wilcox,Simon Baines,Dario Lehoux,Thomas R. Parr
申请号：
US13950202
公开号：
US08629100B2
申请日:
2013.07.24
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of C. difficile and C. difficile spores. Methods for the treatment, prophylaxis and prevention of C. difficile infection and disease in animals, including humans, are described.
